Keywords: first, approval, usa, u/boehringer, ingelheim, mirapex, beohringer
First Approval, In USA, For P&U/Boehringer Ingelheim's Mirapex
Article | 09 July 1997
Beohringer Ingelheim and Pharmacia & Upjohn have received marketingclearance from the US Food and Drug Administration for Mirapex (pramipexole dihydrochloride), a ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
